Epitope-specific immunotherapy of rheumatoid arthritis: Clinical responsiveness occurs with immune deviation and relies on the expression of a cluster of molecules associated with T cell tolerance in a double-blind, placebo-controlled, pilot phase II trial
Eva C. Koffeman, Mark Genovese, Diane Amox, Elissa Keogh, Ernesto Santana, Eric L. Matteson, Arthur Kavanaugh, Jerry A. Molitor, Michael H. Schiff, James O. Posever, Joan M. Bathon, Alan J. Kivitz, Rodrigo Samodal, Francis Belardi, Carolyn Dennehey, Theo Van Den Broek, Femke Van Wijk, Xiao Zhang, Peter Zieseniss, Tho LeBerent A. Prakken, Gary C. Cutter, Salvatore Albani
Dive into the research topics of 'Epitope-specific immunotherapy of rheumatoid arthritis: Clinical responsiveness occurs with immune deviation and relies on the expression of a cluster of molecules associated with T cell tolerance in a double-blind, placebo-controlled, pilot phase II trial'. Together they form a unique fingerprint.